γδT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Vu, Duc M ^a   Tai, Albert ^b   Tatro, Jeffrey B ^a   Karas, Richard H ^a   Huber, Brigitte T ^b   Beasley, Debbie ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; INTERLEUKIN 17; TRIACYLGLYCEROL; APOLIPOPROTEIN E; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; ELASTIN; LEUKOCYTE ANTIGEN; LIPID; LYMPHOCYTE ANTIGEN RECEPTOR;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ARCH; AORTA ATHEROSCLEROSIS; AORTA ROOT; ARTERY INTIMA; ARTERY LESION; ARTICLE; ATHEROGENESIS; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GAMMA DELTA T LYMPHOCYTE; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID STORAGE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOPENIA; MALE; MONOCYTOSIS; MOUSE; NEUTROPHILIA; NONHUMAN; SPLEEN; TH1 CELL; TH17 CELL; ANIMAL; ATHEROSCLEROSIS; BLOOD; COMPLICATION; CYTOLOGY; DEFICIENCY; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LEUKOCYTE DISORDERS; LIPID DIET; METABOLISM; PATHOLOGY; T LYMPHOCYTE; THORACIC AORTA;

MUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AORTA; AORTA, THORACIC; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELASTIN; HYPERCHOLESTEROLEMIA; INTERLEUKIN-17; LEUKOCYTE DISORDERS; LIPIDS; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SPLEEN; T-LYMPHOCYTES; TH17 CELLS;

EID: 84908032405     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109416     Document Type: Article

References (64)

1. Libby P, Lichtman AH, Hansson GK (2013) Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 38: 1092-1104.
2. Hansson GK, Jonasson L (2009) The discovery of cellular immunity in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 29: 1714-1717.
3. Galkina E, Ley K (2009) Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 27: 165-197.
4. Taleb S, Tedgui A, Mallat Z (2010) Adaptive T cell immune responses and atherogenesis. Curr Opin Pharmacol 10: 197-202.
5. Whitman SC, Ravisankar P, Elam H, Daugherty A (2000) Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E2/ 2 mice. Am J Pathol 157: 1819-1824.
6. Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, et al. (2003) Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 23: 454-460.
7. Whitman SC, Ravisankar P, Daugherty A (2002) IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E 2/ 2 mice. J Interferon Cytokine Res 22: 661-670.
8. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, et al. (1997) IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99: 2752-2761.
9. Buono C, Binder CJ, Stavrakis G, Witztum JL, Glimcher LH, et al. (2005) T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci U S A 102: 1596-1601.
10. Gao Q, Jiang Y, Ma T, Zhu F, Gao F, et al. (2010) A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol 185: 5820-5827.
11. Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, et al. (2010) Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121: 1746-1755.
12. Butcher MJ, Gjurich BN, Phillips T, Galkina EV (2012) The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. Circ Res 110: 675-687.
13. Erbel C, Chen L, Bea F, Wangler S, Celik S, et al. (2009) Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 183: 8167-8175.
14. Chen S, Shimada K, Zhang W, Huang G, Crother TR, et al. (2010) IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infectionaccelerated atherosclerosis in mice. J Immunol 185: 5619-5627.
15. Lim H, Kim YU, Sun H, Lee JH, Reynolds JM, et al. (2014) Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity 40: 153-165.
16. Vantourout P, Hayday A (2013) Six-of-the-best: unique contributions of cdT cells to immunology. Nat Rev Immunol 13: 88-100.
17. Cua DJ, Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10: 479-489.
18. Kleindienst R, Xu Q, Willeit J, Waldenberger FR, Weimann S, et al. (1993) Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 142: 1927-1937.
19. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q (1995) Is atherosclerosis an immunologically mediated disease? Immunol Today 16: 27-33.
20. Wick G, Romen M, Amberger A, Metzler B, Mayr M, et al. (1997) Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J 11: 1199-1207.
21. Vanderlaan PA, Reardon CA (2005) Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res 46: 829-838.
22. Elhage R, Gourdy P, Brouchet L, Jawien J, Fouque M-J, et al. (2004) Deleting TCRab++ or CD4 T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol 165: 2013-2018.
23. Elhage R, Gourdy P, Jawien J, Brouchet L, Castano C, et al. (2005) The atheroprotective effect of 17beta-estradiol depends on complex interactions in adaptive immunity. Am J Pathol 167: 267-274.
24. Cheng HY, Wu R, Gebre AK, Hanna RN, Smith DJ, et al. (2013) Increased cholesterol content in gammadelta (cd) T lymphocytes differentially regulates their activation. PLoS One 8: e63746.
25. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 89: 4471-4475.
26. Itohara S, Mombaerts P, Lafaille J, Iacomini J, Nelson A, et al. (1993) T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell 72: 337-348.
27. Higashimori M, Tatro JB, Moore KJ, Mendelsohn ME, Galper JB, et al. (2011) Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 31: 50-57.
28. Galkina E, Kadl A, Sanders J, Varughese D, Sarembock IJ, et al. (2006) Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 203: 1273-1282.
29. Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, et al. (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117: 1649-1657.
30. Rosas M, Thomas B, Stacey M, Gordon S, Taylor PR (2010) The myeloid 7/4-antigen defines recently generated inflammatory macrophages and is synonymous with Ly-6B. J Leukoc Biol 88: 169-180.
31. McGillicuddy CJ, Carrier MJ, Weinberg PD (2001) Distribution of lipid deposits around aortic branches of mice lacking LDL receptors and apolipoprotein E. Arterioscler Thromb Vasc Biol 21: 1220-1225.
32. Martel C, Li W, Fulp B, Platt AM, Gautier EL, et al. (2013) Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest 123: 1571-1579.
33. Lohmann C, Schafer N, von Lukowicz T, Sokrates Stein MA, Boren J, et al. (2009) Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. Atherosclerosis 207: 360-367.
34. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O (2010) Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122: 1837-1845.
35. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, et al. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117: 195-205.
36. Huber S, Shi C, Budd RC (2002) Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol 76: 6487-6494.
37. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, et al. (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
38. Do JS, Visperas A, Dong C, Baldwin WM, 3rd, Min B (2011) Cutting edge: Generation of colitogenic Th17 CD4 T cells is enhanced by IL-17+ gammadelta T cells. J Immunol 186: 4546-4550.
39. Cheng HY, Wu R, Hedrick CC (2014) Gammadelta (cd) T lymphocytes do not impact the development of early atherosclerosis. Atherosclerosis 234: 265-269.
40. VanderLaan PA, Reardon CA, Getz GS (2004) Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol. 12-22.
41. Casetti R, Agrati C, Wallace M, Sacchi A, Martini F, et al. (2009) Cutting edge: TGF-beta1 and IL-15 Induce FOXP3 + gammadelta regulatory T cells in the presence of antigen stimulation. J Immunol 183: 3574-3577.
42. Li X, Kang N, Zhang X, Dong X, Wei W, et al. (2011) Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus. J Immunol 186: 6693-6700.
43. Ye J, Ma C, Hsueh EC, Eickhoff CS, Zhang Y, et al. (2013) Tumor-derived cd regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence. J Immunol 190: 2403-2414.
44. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK (1986) Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6: 131-138.
45. Moos MP, John N, Grabner R, Nossmann S, Gunther B, et al. (2005) The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25: 2386-2391.
46. Houtkamp MA, de Boer OJ, van der Loos CM, van der Wal AC, Becker AE (2001) Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J Pathol 193: 263-269.
47. Campbell KA, Lipinski MJ, Doran AC, Skaflen MD, Fuster V, et al. (2012) Lymphocytes and the adventitial immune response in atherosclerosis. Circ Res 110: 889-900.
48. Maiellaro K, Taylor WR (2007) The role of the adventitia in vascular inflammation. Cardiovasc Res 75: 640-648.
49. Taleb S, Tedgui A, Mallat Z (2010) Interleukin-17: friend or foe in atherosclerosis? Curr Opin Lipidol 21: 404-408.
50. Danzaki K, Matsui Y, Ikesue M, Ohta D, Ito K, et al. (2012) Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 32: 273-280.
51. Madhur MS, Funt SA, Li L, Vinh A, Chen W, et al. (2011) Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein edeficient mice. Arterioscler Thromb Vasc Biol 31: 1565-1572.
52. Gistera A, Robertson AK, Andersson J, Ketelhuth DF, Ovchinnikova O, et al. (2013) Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med 5: 196ra100.
53. Eid RE, Rao DA, Zhou J, Lo SF, Ranjbaran H, et al. (2009) Interleukin-17 and interferon-gamma are produced concomitantly by human coronary arteryinfiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 119: 1424-1432.
54. Shibata K, Yamada H, Hara H, Kishihara K, Yoshikai Y (2007) Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 178: 4466-4472.
55. Gray EE, Ramirez-Valle F, Xu Y, Wu S, Wu Z, et al. (2013) Deficiency in IL-17-committed Vc4(+) cd T cells in a spontaneous Sox13-mutant CD45.1(+) congenic mouse substrain provides protection from dermatitis. Nat Immunol 14: 584-592.
56. Petermann F, Rothhammer V, Claussen MC, Haas JD, Blanco LR, et al. (2010) gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33: 351-363.
57. Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, et al. (2000) Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol 164: 4783-4789.
58. Schwarzenberger P, La Russa V, Miller A, Ye P, Huang W, et al. (1998) IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 161: 6383-6389.
59. Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, et al. (2008) Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 102: 209-217.
60. Doring Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, et al. (2012) Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res 110: 1052-1056.
61. Soehnlein O (2012) Multiple roles for neutrophils in atherosclerosis. Circ Res 110: 875-888.
62. Soehnlein O, Zernecke A, Eriksson EE, Rothfuchs AG, Pham CT, et al. (2008) Neutrophil secretion products pave the way for inflammatory monocytes. Blood 112: 1461-1471.
63. Bjorkegren JL, Hagg S, Talukdar HA, Foroughi Asl H, Jain RK, et al. (2014) Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis. PLoS Genet 10: e1004201.
64. Roselaar SE, Kakkanathu PX, Daugherty A (1996) Lymphocyte populations in atherosclerotic lesions of apoE 2/2 and LDL receptor 2/2 mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 16: 1013-1018.